Mark A Hlatky Selected Research

EPO protocol

9/2008

Facility factors dominate the ability to achieve target haemoglobin levels in haemodialysis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark A Hlatky Research Topics

Disease

22	Myocardial Infarction 01/2023 - 09/2002
19	Coronary Artery Disease (Coronary Atherosclerosis) 10/2018 - 02/2002
18	Coronary Disease (Coronary Heart Disease) 01/2023 - 04/2003
13	Heart Failure 01/2020 - 05/2002
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 09/2006
10	Type 2 Diabetes Mellitus (MODY) 03/2022 - 11/2007
10	Hypertension (High Blood Pressure) 10/2021 - 09/2003
8	Stroke (Strokes) 01/2023 - 10/2010
8	Atrial Fibrillation 01/2020 - 01/2012
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017 - 02/2002
5	Hemorrhage 01/2020 - 09/2011
5	Stable Angina 09/2013 - 02/2006
5	Cardiac Sudden Death (Sudden Cardiac Arrest) 10/2005 - 09/2002
4	Inflammation (Inflammations) 10/2019 - 10/2013
4	Left Ventricular Dysfunction 09/2015 - 10/2005
4	Heart Diseases (Heart Disease) 10/2013 - 09/2003
3	ST Elevation Myocardial Infarction 05/2016 - 09/2011
3	Chronic Kidney Failure (Chronic Renal Failure) 03/2016 - 12/2012
3	Diabetes Mellitus 05/2015 - 10/2010
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2023 - 10/2022
2	Hypercholesterolemia 10/2021 - 09/2003
2	Overweight 01/2021 - 12/2014
2	Hyperlipidemias (Hyperlipidemia) 01/2021 - 09/2007
2	Cardiomyopathies (Cardiomyopathy) 10/2020 - 10/2005
2	Ischemic Stroke 01/2020 - 03/2014
2	Hypoglycemia (Reactive Hypoglycemia) 10/2018 - 06/2009
2	Atherosclerosis 12/2015 - 05/2008
2	Insulin Resistance 05/2015 - 02/2007
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2015 - 12/2014
2	Acute Kidney Injury (Acute Renal Failure) 09/2014 - 11/2013
2	Acute Coronary Syndrome 02/2014 - 05/2013
2	Systolic Heart Failure 11/2013 - 09/2013
2	Chronic Renal Insufficiency 05/2013 - 03/2013
2	Cardiac Arrhythmias (Arrythmia) 01/2012 - 10/2005
2	Sudden Death 10/2005 - 09/2002
1	Hyperemia 03/2024
1	Myalgia 01/2023
1	Neoplasms (Cancer) 01/2023
1	Abdominal Aortic Aneurysm 01/2021
1	Thromboembolism 01/2020
1	Uremia 10/2019
1	Infections 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Pulmonary Embolism 01/2018

Drug/Important Bio-Agent (IBA)

8	Insulin (Novolin)FDA Link 01/2018 - 06/2009
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 09/2003
5	Hormones (Hormone)IBA 01/2021 - 02/2002
5	CalciumIBA 10/2019 - 01/2007
5	Biomarkers (Surrogate Marker)IBA 05/2015 - 09/2006
4	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 11/2006
4	omega-Chloroacetophenone (Mace)IBA 01/2022 - 03/2014
4	LipidsIBA 10/2021 - 10/2010
3	LDL CholesterolIBA 10/2021 - 10/2010
3	C-Reactive ProteinIBA 01/2019 - 06/2011
3	MetalsIBA 10/2018 - 11/2012
3	Rosiglitazone (Avandia)FDA Link 12/2007 - 11/2007
2	CholesterolIBA 10/2021 - 11/2006
2	Proton Pump InhibitorsIBA 01/2019 - 10/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 11/2007
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2017 - 09/2003
2	LeptinIBA 01/2016 - 02/2007
2	Adenosine Triphosphate (ATP)IBA 01/2016 - 11/2006
2	Clopidogrel (Plavix)FDA Link 06/2014 - 02/2014
2	Proteins (Proteins, Gene)FDA Link 11/2010 - 12/2007
2	Progestins (Progestagens)IBA 09/2003 - 02/2002
2	Estrogens (Estrogen)FDA Link 09/2003 - 02/2002
2	Anti-Arrhythmia AgentsIBA 09/2002 - 09/2002
1	P 11 (P-11)IBA 03/2024
1	Vitamin D FDA LinkGeneric 01/2023
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2022
1	SodiumIBA 03/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2022
1	oxidized low density lipoproteinIBA 10/2021
1	Lipoprotein(a)IBA 01/2021
1	apixabanIBA 01/2020
1	N(4)-oleylcytosine arabinosideIBA 01/2020
1	RivaroxabanIBA 01/2020
1	Phosphorus (Red Phosphorus)IBA 10/2019
1	Monoclonal AntibodiesIBA 01/2019
1	canakinumab FDA Link 01/2019
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2019
1	Troponin T (Troponin T1)IBA 10/2018
1	TroponinIBA 10/2018
1	Everolimus FDA Link 01/2018
1	ThiazolidinedionesIBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	meglitinideIBA 01/2018

Therapy/Procedure

33	Therapeutics 01/2023 - 02/2002
17	Percutaneous Coronary Intervention 01/2023 - 09/2006
14	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2023 - 10/2005
6	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 10/2020 - 09/2002
4	Stents 10/2018 - 11/2012
4	Drug Therapy (Chemotherapy) 04/2016 - 06/2007
3	Catheter Ablation 01/2020 - 01/2012
3	Cardiac Resynchronization Therapy 09/2015 - 09/2004
3	Defibrillators (Defibrillator) 10/2005 - 05/2002
2	Drug-Eluting Stents 01/2023 - 03/2016
2	Aftercare (After-Treatment) 01/2017 - 10/2010
2	Secondary Prevention 09/2002 - 02/2002